644
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Defining and measuring recovery from myalgic encephalomyelitis and chronic fatigue syndrome: the physician perspective

ORCID Icon, , & ORCID Icon
Pages 158-165 | Received 06 May 2017, Accepted 19 Sep 2017, Published online: 05 Oct 2017
 

Abstract

Purpose: To inform an operationalised definition of recovery from myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS) for research and practice. Without a consensus on defining and measuring recovery, there will continue to be controversy amongst researchers, clinicians, and patients when interpreting treatment outcomes.

Method: This study explores physicians’ views on recovery from ME and CFS. We conducted semi-structured interviews with 10 physician participants who are experts in the ME and CFS field. Our deductive thematic analysis, using a realist perspective, provided a framework for differentiating recovery and significant improvement.

Results: Physicians conceptualised recovery as complete symptom remission and a return to premorbid functioning (adjusted for with age), whereas they viewed significant improvement as a substantial reduction in symptoms with considerable functional gains, where patients may operate in daily life but still must cope or be treated.

Conclusions: Our findings provide recommendations and approaches for measuring: daily functioning, symptomatology, quality of life, and physical functioning.

    Implications for rehabilitation

  • Physicians viewed recovery as complete symptom remission and a return to premorbid functioning (adjusted for with age).

  • Recovery from myalgic encephalomyelitis and chronic fatigue syndrome should be viewed as multidimensional, considering patients’ daily life, psychosocial functioning, and overall physical functioning.

  • These findings can improve practitioner-client interactions, as they provide recommendations for measuring recovery in research and practice.

Acknowledgements

Thank you to all of the physicians who dedicated their time to this study. We are very grateful for their continued service to the ME and CFS patient community.

Disclosure statement

The authors report no declarations of interest.

Additional information

Funding

This study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development [grant number HD072208].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.